Morning Market Gainers

surged 108.33 percent to $6.25 on going private bid of $8.75 per share.

shares jumped 33.82 percent to $11.29 as TELESTAR Phase 3 clinical trial met primary endpoint.

shares gained 12.53 percent to $45.80 on flu vaccine study results.

shares gained 7.81 percent to $2.76 as the company announced better-than-expected Q2 results.

rose 6.82 percent to $5.04 after the company reported in-line earnings for the second quarter.

shares jumped 6.60 percent to $3.70 following the announcement of a $2.5 million contract with Fresno-based Baloian Packing.

shares climbed 3.44 percent to $5.11 after the company reported the FDA Emergency Use Authorization for its Ebola Rapid Diagnostic test.